Brain metastases from breast cancer: management approach.
J Cancer Res Ther
;
2007 Jul-Sep; 3(3): 157-65
Artículo
en Inglés
| IMSEAR
| ID: sea-111369
ABSTRACT
Brain metastases are a significant cause of morbidity and mortality in patients with breast cancer. HER-2 positivity is an increasingly recognized risk factor for the development of brain metastases. Although considerable progress has been made in the treatment of this complication, supportive measures like steroids, anti-seizure medication and whole-brain radiation remain the cornerstones of management in the majority of patients. The current review discusses the above and other issues like surgical excision, stereotactic radiotherapy, adjuvant radiation, radiosensitization and chemotherapy. A brief discussion of the recent evidence for the use of 'HER-1/ HER-2'-targeted therapy is also present.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Neoplasias Encefálicas
/
Neoplasias de la Mama
/
Femenino
/
Humanos
Tipo de estudio:
Factores de riesgo
Idioma:
Inglés
Revista:
J Cancer Res Ther
Asunto de la revista:
Neoplasms
/
Therapeutics
Año:
2007
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS